Fig. 5From: Influence of tumour size on the efficacy of targeted alpha therapy with 213Bi-[DOTA0,Tyr3]-octreotate a–d 99mTc-DMSA renal SPECT images in H69 control (a), 213Bi-DOTATATE-treated H69 mice (b), CA20948 control (c) and 213Bi-DOTATATE-treated CA20948 mice (d). e Renal uptake (in kBq) of 99mTc-DMSA (25 MBq) in H69 and CA20948 tumour-bearing mice after therapy with 213Bi-DOTATATE or DOTATATEBack to article page